Adipocyte (Jan 2020)

A new human adipocyte model with PTEN haploinsufficiency

  • Franziska Kässner,
  • Anna Kirstein,
  • Norman Händel,
  • Gordian L. Schmid,
  • Kathrin Landgraf,
  • Antje Berthold,
  • Astrid Tannert,
  • Michael Schaefer,
  • Martin Wabitsch,
  • Wieland Kiess,
  • Antje Körner,
  • Antje Garten

DOI
https://doi.org/10.1080/21623945.2020.1785083
Journal volume & issue
Vol. 9, no. 1
pp. 290 – 301

Abstract

Read online

Few human cell strains are suitable and readily available as in vitro adipocyte models. We used resected lipoma tissue from a patient with germline phosphatase and tensin homolog (PTEN) haploinsufficiency to establish a preadipocyte cell strain termed LipPD1 and aimed to characterize cellular functions and signalling pathway alterations in comparison to the established adipocyte model Simpson-Golabi-Behmel-Syndrome (SGBS) and to primary stromal-vascular fraction cells. We found that both cellular life span and the capacity for adipocyte differentiation as well as adipocyte-specific functions were preserved in LipPD1 and comparable to SGBS adipocytes. Basal and growth factor-stimulated activation of the PI3 K/AKT signalling pathway was increased in LipPD1 preadipocytes, corresponding to reduced PTEN levels in comparison to SGBS cells. Altogether, LipPD1 cells are a novel primary cell model with a defined genetic lesion suitable for the study of adipocyte biology.

Keywords